No Data
No Data
Where CareDx Stands With Analysts
Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on CareDx (NASDAQ:CDNA) in the last three months.The following table encapsulates their recent
Express News | Goldman Sachs Maintains Buy on CareDx, Raises Price Target to $16
CareDx, Inc (NASDAQ:CDNA) Held Back By Insufficient Growth Even After Shares Climb 31%
Despite an already strong run, CareDx, Inc (NASDAQ:CDNA) shares have been powering on, with a gain of 31% in the last thirty days. The last 30 days bring the annual gain to a very sharp 80%.
CareDx to Report Second Quarter 2024 Financial Results
Nephron Initiates CareDx at Hold Rating With $15 Price Target
07:57 AM EDT, 07/10/2024 (MT Newswires) -- Nephron Initiates CareDx at Hold Rating With $15 Price
Craig-Hallum Maintains CareDx(CDNA.US) With Buy Rating
Craig-Hallum analyst William Bonello maintains $CareDx(CDNA.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 75.0% and a total average return of 39.3% over the past